NIAID to Hold Closed Meeting on Biodefense Medical Countermeasure Funding Contracts + Grants May 7, 2020 …
Alexion to Initiate Phase 3 Study of Rare Blood-Disorder Drug in Severe COVID-19 Patients Medical Countermeasures April 20, 2020 …
BARDA Facilitates Development of Immunotherapies for COVID-19 Patients Industry News April 14, 2020 …
JPEO-CBRND, BARDA Partner with SAb Biotherapeutics to Develop COVID-19 Therapeutic Medical Countermeasures April 1, 2020 …
AbCellera and Eli Lilly to Co-Develop COVID-19 Therapeutic Antibodies Medical Countermeasures March 12, 2020 …
Passive Immunization with mAbs Against Aerosolized Ricin Toxin Medical Countermeasures March 6, 2020 …
Vir Biotechnology Identifies Two Antibodies That Bind to the Spike Protein of SARS-CoV-2 Medical Countermeasures February 12, 2020 …
HHS, Regeneron Collaborate to Develop COVID-19 Treatment Using VelociSuite Technology Medical Countermeasures February 4, 2020 …
First-Ever Therapeutic Antibody Cocktail for Sudan Virus Shows Promise in Animal Studies Medical Countermeasures February 4, 2020 …
AbCellera is Mobilizing a Response to the Novel Coronavirus Outbreak as Part of its DARPA P3 Program Medical Countermeasures January 29, 2020 …
Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses Pathogens January 7, 2020 …
BioFactura’s Smallpox Biodefense Therapeutic Awarded $67M BARDA Contract Contracts + Grants September 26, 2019 …
Ology Bioservices Awarded DoD Contract for Countermeasures Against Bioweapons Industry News April 15, 2019 …
Ridgeback Biotherapeutics Licenses mAb114 Ebola Treatment from NIAID Industry News December 13, 2018 …
Landmark Ebola Study Provides Deep Scan of Therapeutic Antibody Combinations Medical Countermeasures August 9, 2018 …